Daniel Griffith Anderson serves as Executive at Sigilon Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Daniel Griffith Anderson has executed 1 insider transactions totaling $2.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 2, 2021 involved selling 200,000 shares valued at $2.0M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 2, 2021 | SGTX | $2.0M | Sale | 200,000 | $10.00 | Discretionary |
Daniel Griffith Anderson currently holds 2,022,222 shares of Sigilon Therapeutics, Inc. (SGTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Griffith Anderson has been a net seller of SGTX stock. They have purchased $0 and sold $2.0M worth of shares.
Daniel Griffith Anderson's most recent insider trade was on Jun 2, 2021, when they sold 200,000 shares at $10.00 per share.
Get notified when new Form 4 filings are submitted